|
|
|
Taro Announces Joining of CEO
|
|
Business Wire India | 02 Sep, 2017
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (âTaroâ or the âCompanyâ) announced today that Mr. Uday Baldota has joined the Company as its Chief Executive Officer (âCEOâ) effective August 28, 2017. Since December 2016, Mr. Baldota has served as a member of Taroâs Board of Directors (âTaro Boardâ).
Mr. Baldota replaces Mr. Abhay Gandhi, who served in the role of Interim Chief Executive Officer since January 1, 2017. Mr. Gandhi will continue in his role as Vice Chairman of the Taro Board and as the CEO of the Sun Pharma North America operations.
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Companyâs website at www.taro.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170901005726/en/
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Customs Exchange Rates |
| Currency |
Import |
Export |
US Dollar
|
₹84.00
|
₹82.25 |
UK Pound
|
₹104.65
|
₹108.10 |
Euro
|
₹92.50
|
₹89.35 |
| Japanese
Yen |
₹56.10 |
₹54.40 |
| As on 25 Jul, 2025 |
|
|
| Daily Poll |
 |
 |
| Who do you think will benefit more from the India - UK FTA in the long run?
|
|
|
|
|
|
| Commented Stories |
 |
|
|
|
|
|
| |
|
